Le paper - Wolf Table of Contents 1.0

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: Wolf Table of Contents 1.0 Introduction..........................................................................................................2 2.0 Overview of Peptides...........................................................................................2 2.1 Theory of Operation.............................................................................................4 3.0 Drugs in the Body................................................................................................4 3.1 Peptides ...............................................................................................................4 3.2 Obstacles with Peptide Drugs..............................................................................5 3.2.1 Half-lives...........................................................................................................5 3.2.2 Synthesis...........................................................................................................6 3.3 Micromolecules....................................................................................................7 4.0 Peptide Treatments used in Medical Conditions.................................................7 4.1 Cancer..................................................................................................................8 4.2 Antimicrobials......................................................................................................8 4.3 Alzheimers Disease and Creutzfeld-Jakob Disease............................................8 5.0 Conclusion: the Future of Peptides......................................................................9 6.0 References............................................................................................................10 List of Figures Figure 1. 36-Residue peptide within the PC2 binding protein 7B2 ..........................3 Figure 2. 3D model of caffeine molecule..................................................................7 Figure 3. Enzyme specificity to peptides and micromolecules..................................7 List of Tables Table 1. Peptide usefulness as a drug and a vaccine .................................................5 1 Wolf 1.0 Introduction Most drugs in pill form consist of an active micromolecule and an inactive binding substance. The micromolecule is usually composed of around 20 atoms. The purpose of the micromolecule is to react with different proteins within the body to create a chemical reaction that treats the condition it targets. However, the micromolecule is so small that it is not sufficiently specific and will usually react with both the target proteins and other proteins. An unwanted side effect occurs when the micromolecule reacts with a non- target protein....
View Full Document

Page1 / 10

Le paper - Wolf Table of Contents 1.0

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online